On December 5, 2022, SonoThera, Inc. closed the transaction. The round of funding led by Arch Venture Partners, L.P.. The transaction also involved participation from IIF Management Company, LLC, Johnson & Johnson Innovation - JJDC, Inc., Vertex Ventures HC, Medical Excellence Capital, LLC, Eli Lilly and Company, Alexandria Venture Investments, LLC, Lifespan Investments B.v., Formic Ventures, Foothill Ventures, LLC and Wilson Sonsini Goodrich & Rosati, P.C.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
735 USD | -2.77% | +0.20% | +26.08% |
05-03 | News Highlights : Top Company News of the Day - Friday at 5 PM ET | DJ |
05-03 | News Highlights : Top Company News of the Day - Friday at 7 PM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- SonoThera, Inc. announced that it has received $60.75 million in funding from a group of investors